Ultragenyx Pharmaceutical Inc.

Mirae Asset Global Investments Co., Ltd. RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

Shares

4,688

Value ($000)

108

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	108	0.0%	4,688	12/31/2025
2025 Q3	11/3/2025	112	0.0%	3,726	9/30/2025
2025 Q2	7/21/2025	133	0.0%	3,652	6/30/2025
2025 Q1	4/24/2025	117	0.0%	3,095	3/31/2025
2024 Q4	1/27/2025	134	0.0%	3,077	12/31/2024
2024 Q3	10/23/2024	181	0.0%	3,333	9/30/2024
2024 Q2	7/30/2024	103	0.0%	2,482	6/30/2024
2024 Q1	5/1/2024	8,762	0.0%	230,767	3/31/2024
2023 Q4	1/24/2024	5,182	0.0%	108,355	12/31/2023
2023 Q3	10/26/2023	7,521	0.0%	210,968	9/30/2023
2023 Q2	8/10/2023	8,866	0.0%	192,123	6/30/2023
2023 Q1	5/4/2023	9,350	0.0%	233,156	3/31/2023
2022 Q4	2/9/2023	10,409	0.0%	224,677	12/31/2022
2022 Q3	11/10/2022	5,487	0.0%	132,492	9/30/2022
2022 Q2	8/15/2022	7,645	0.0%	128,159	6/30/2022
2022 Q1	5/10/2022	9,942	0.0%	136,906	3/31/2022
2021 Q4	2/8/2022	13,515	0.0%	160,727	12/31/2021
2021 Q3	11/15/2021	11,131	0.0%	123,407	9/30/2021
2021 Q2	8/11/2021	9,764	0.0%	102,395	6/30/2021
2021 Q1	5/13/2021	10,049	0.0%	88,261	3/31/2021
2020 Q4	2/10/2021	7,558	0.0%	54,598	12/31/2020
2020 Q3	11/12/2020	3,644	0.0%	44,336	9/30/2020
2020 Q2	8/11/2020	2,476	0.0%	31,645	6/30/2020
2020 Q1	5/12/2020	943	0.0%	21,242	3/31/2020
2019 Q4	2/12/2020	811	0.0%	18,994	12/31/2019